Abstract
Pediatric inflammatory bowel disease (IBD) becomes adult inflammatory bowel disease, but several considerations require particular attention when children develop the disease. The disease generally manifests with active inflammation in children, whereas obstruction from "burnt-out" disease may become more prevalent with age. Because children are still growing, avoiding the growth-suppressing affects of the disease (and of steroid pharmacotherapy) is important in pediatric patients, in contrast to adults. Finally, the longer life expectancy of children than adults mandates even more attention to long-term safety issues in young patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
